CBS-3 Highlights Cancer Epigenetics Institute and Dr. Johnathan Whetstine’s Lung Cancer Research

Whe
 Johnathan Whetstine, PhD, Director of the Cancer Epigenetics Institute

We’re thrilled to highlight the recent CBS-3 feature on Johnathan Whetstine, PhD, director of the Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center, which showcased both his groundbreaking research and his personal commitment to lung cancer advocacy.

Dr. Whetstine’s lab is at the forefront of understanding how DNA and epigenetic changes drive cancer progression and resistance to treatment. His team’s work, particularly focused on lung cancer, aims to uncover mechanisms that could lead to more effective therapies—efforts that have earned him multiple Lung Cancer Discovery Awards.

The CBS-3 segment also shared a personal side of Dr. Whetstine’s story: his mother, Jeanne Whetstine, is a survivor of four different cancers. Together, they will participate in this weekend’s Lung Force Walk at the Philadelphia Zoo, underscoring the powerful connection between research and real lives.

Founded in 2021, the Cancer Epigenetics Institute serves as a national hub for cutting-edge research, bringing together scientists to study how epigenetic mechanisms promote cancer and resistance to therapy. The institute is driving collaborations that translate discoveries into real-world advances in cancer care.

This recognition reflects the CEI’s mission to bridge innovative science with meaningful impact. Congratulations to Dr. Whetstine and the entire CEI team for their continued leadership in the fight against cancer.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text